One example is the American Cancer Society (ACS). The Yale report found that the American Cancer Society’s chief executive officer, Dr. Karen Knudsen, is also a member of Genentech’s Scientific Resource Board. Genentech markets and develops cancer drugs and can benefit if the ACS endorses or promotes its products.
